-

Komatsu Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: Komatsu Ltd. 2024" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into Komatsu's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Komatsu Ltd (Komatsu) is an equipment manufacturer company. It develops and sells construction, mining equipment, utilities, forest machines and industrial machinery. Through its manufacturing and technology innovation, it also supplies products, services, and solutions in response to social needs.

The company provides construction and mining equipment such as excavating equipment, loading equipment, grading and roadbed preparation equipment, hauling equipment, forestry equipment, tunneling machines, recycling equipment, industrial vehicles, engines and components, casting products, and logistics other equipment.

It also offers industrial machinery such as metal forging and stamping presses, sheet metal machines, machine tools, defense systems, and temperature control equipment. Komatsu operates through a domestic and international sales and distribution network. The company has manufacturing plants in the US, Japan, Germany, the UK, Sweden, Canada, Indonesia, Brazil, Italy, China and Thailand.

The report provides information and insights into Komatsu's tech activities, including:

  • Insights of its digital transformation strategies and innovation programs.
  • Overview of technology initiatives covering partnerships and product launches.
  • Insights on each technology initiative including technology theme, objective, and benefits.
  • Details of estimated ICT budgets and major ICT contracts.

Reasons to Buy

  • Gain insights into Komatsu's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches and partnerships.

Key Topics Covered:

  • Overview
  • Digital Transformation Strategy
  • Accelerators, Incubators, and Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Acquisitions
  • Partnership & Acquisition Network Map
  • ICT Budget
  • Key Executives

A selection of companies mentioned in this report includes, but is not limited to:

  • Microsoft
  • TimeXtender
  • AWS
  • Advantech
  • Cummins
  • Toyota
  • Cesium
  • Moog
  • Clue
  • Moovila
  • iVolve Holdings Pty Ltd.

For more information about this company profile visit https://www.researchandmarkets.com/r/nwtzlz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global Forecast to 2033: Growing Shift of Weekly Injectables Toward Orals and Multi-Agonists - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% The report will help market leaders/new...

Liraglutide and Semaglutide Global Strategic Business Analysis Report 2025-2030: Regulatory Pipeline for Pediatric and Adolescents With Obesity Creates Long-Term Market Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 Billion in 2024 and is projected to reach US$29.8 Billion by 2030, growing at a CAGR of 9.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Liraglutide and s...

Asia Pacific Mining Industry Review 2025: Production by Country, Major Operating Mines, Major Exploration, and Development Projects - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Mining Review 2025" report has been added to ResearchAndMarkets.com's offering. The report contains an overview of the Asia Pacific mining industry including key macroeconomic trends, commodity price, and operating environment across major and emerging mining markets. It provides detailed information on production by country, major operating mines, major exploration, and development projects. Asia Pacific is one of the world's leading mining regions, e...
Back to Newsroom